| Literature DB >> 31866984 |
Jessey Erath1, Sergej Djuranovic1, Slavica Pavlovic Djuranovic1.
Abstract
Malaria is caused by unicellular apicomplexan parasites of the genus Plasmodium, which includes the major human parasite Plasmodium falciparum. The complex cycle of the malaria parasite in both mosquito and human hosts has been studied extensively. There is tight control of gene expression in each developmental stage, and at every level of gene synthesis: from RNA transcription, to its subsequent translation, and finally post-translational modifications of the resulting protein. Whole-genome sequencing of P. falciparum has laid the foundation for significant biological advances by revealing surprising genomic information. The P. falciparum genome is extremely AT-rich (∼80%), with a substantial portion of genes encoding intragenic polyadenosine (polyA) tracks being expressed throughout the entire parasite life cycle. In most eukaryotes, intragenic polyA runs act as negative regulators of gene expression. Recent studies have shown that translation of mRNAs containing 12 or more consecutive adenosines results in ribosomal stalling and frameshifting; activating mRNA surveillance mechanisms. In contrast, P. falciparum translational machinery can efficiently and accurately translate polyA tracks without activating mRNA surveillance pathways. This unique feature of P. falciparum raises interesting questions: (1) How is P. falciparum able to efficiently and correctly translate polyA track transcripts, and (2) What are the specifics of the translational machinery and mRNA surveillance mechanisms that separate P. falciparum from other organisms? In this review, we analyze possible evolutionary shifts in P. falciparum protein synthesis machinery that allow efficient translation of an AU rich-transcriptome. We focus on physiological and structural differences of P. falciparum stage specific ribosomes, ribosome-associated proteins, and changes in mRNA surveillance mechanisms throughout the complete parasite life cycle, with an emphasis on the mosquito and liver stages.Entities:
Keywords: AT rich genome; mRNA surveillance; mRNA translation; plasmodium; ribosomes
Year: 2019 PMID: 31866984 PMCID: PMC6908487 DOI: 10.3389/fmicb.2019.02823
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Schematic presentation of P. falciparum life cycle and stage-specific ribosomal RNAs (A and S type). Human infection by P. falciparum begins when an infected female anopheline mosquito inoculates sporozoites into the bloodstream during feeding. The sporozoites invade liver cells and transform into trophozoites. In 6–8 days one mature schizont will release thousands of liver-stage merozoites into the bloodstream (exoerythrocytic schizogony, the first proliferative stage). The second asexual proliferative stage blood stage (erythrocytic schizogony) starts when the liver-stage merozoites invade the erythrocytes About 14–16 erythrocytic merozoites are generated in a 48-h cycle for re-infection and it is the point when the symptoms start. The merozoites may differentiate into single gametocytes, the initial stage of the sexual reproduction (gametogenesis) or continue the asexual cycle. Mosquito infection begins when the gametocytes are taken by mosquito with the blood meal. The male microgametocyte exflagellates into individual microgametes and fertilizes the female macrogamete. The zygote transforms into a motile ookinete, penetrates the mosquito midgut and develops into an oocyst. After 9–14 days, thousands of sporozoites are differentiated in the mature oocyst (sporogony), the only multiplicative stage in the mosquito. Mature sporozoites invade salivary glands and with the next blood meal the cycle continues.
Comparison of AT-richness and polyA track gene ratios over selected Eukaryotic species.
| 76.22% | 63.54% | |
| 75.93% | 62.93% | |
| 72.57% | 20.96% | |
| 72.50% | 28.19% | |
| 60.39% | 5.51% | |
| 59.77% | 41.42% | |
| 57.94% | 1.93% | |
| 53.51% | 38.85% | |
| 50.66% | 1.10% | |
| 50.60% | 2.17% | |
| 49.98% | 1.40% | |
| 49.19% | 2.89% | |
| 46.83% | 2.74% | |
| 42.88% | 1.01% | |
| 37.63% | 0.19% | |
| 37.52% | 0.05% | |
| 37.50% | 0.12% | |
| 37.06% | 0.11% | |
| 31.38% | 0.10% | |
| 29.37% | 0.33% |
Comparison of AT-Richness and polyA track gene ratios over selected Plasmodium species.
| 78.81% | 71.77% | |
| 78.43% | 79.18% | |
| 76.26% | 68.26% | |
| 77.03% | 64.96% | |
| 76.22% | 63.54% | |
| 74.46% | 63.37% | |
| 75.93% | 62.93% | |
| 74.91% | 62.58% | |
| 77.56% | 61.76% | |
| 76.71% | 61.02% | |
| 76.55% | 60.60% | |
| 76.67% | 60.57% | |
| 76.49% | 60.45% | |
| 76.75% | 60.42% | |
| 76.56% | 60.33% | |
| 76.56% | 59.98% | |
| 76.50% | 59.81% | |
| 76.65% | 59.72% | |
| 75.20% | 51.06% | |
| 59.77% | 41.42% | |
| 59.76% | 41.42% | |
| 53.51% | 38.85% | |
| 57.91% | 33.83% | |
| 56.37% | 31.12% |
FIGURE 2Plasmodium falciparum ribosomal protein expression over life cycle. RNAseq data (López-Barragán et al., 2011; Zanghì et al., 2018) for the 82 cytosolic ribosomal proteins was queried from PlasmoDB (Aurrecoechea et al., 2009) for ring, early trophozoite, late trophozoite, schizont, gametocyte II, gametocyte V, ookinete, oocyst, and sporozoite stages. Data is displayed in log scale as a violin plot, showing the general trend of ribosomal protein transcripts. Data for each ribosomal protein is represented as a dot in the plot.
FIGURE 3Expression of P. falciparum genes in different hosts. The data was queried from PlasmoDB (Aurrecoechea et al., 2009; López-Barragán et al., 2011; Zanghì et al., 2018) for protein-coding genes with expression data greater than or equal to the 80th percentile for ring, early trophozoite, late trophozoite, schizont, gametocyte II, gametocyte V, ookinete, oocyst, and sporozoite stages. P. falciparum genes enriched in the mosquito host (A), human host (C), and polyA genes for each (B and D, respectively) are as previously defined. RNAseq data for all stages in both hosts for these gene sets are displayed in log scale as a violin plot with all data points for comparison.
FIGURE 4Venn Diagram of P. falciparum gene expression from RNAseq data. The expression data greater than or equal to the 80th percentile for ring, early trophozoite, late trophozoite, schizont, gametocyte II, gametocyte V, ookinete, oocyst, and sporozoite stages was queried (López-Barragán et al., 2011; Zanghì et al., 2018). Mosquito stage total genes were defined as those with expression data greater than or equal to the 80th percentile during gametocyte V, ookinete, oocyst, or sporozoite stages. Mosquito host-specific genes are defined as above, but solely in mosquito host stages. Total parasite genes expressed in the human host were defined as those with expression data greater than or equal to the 80th percentile during sporozoite, ring, early trophozoite, late trophozoite, schizont, gametocyte II, or gametocyte V stages. Enriched parasite genes expressed in the human host are defined as above, but solely in human host stages. PolyA genes are those defined as having one or more runs of twelve or more consecutive adenosines in the coding region of the gene.
Comparison of translation quality control factors in P. falciparum and its mosquito and human hosts.
| NMD | eRF1, eRF3, UPF1, UPF2, UPF3A/UPF3B, eIF4AIII, MLN51, Y14/MAGOH, BTZ, SMG1, SMG5, SMG6, SMG7, PP2, Musashi, PABP1 | eRF1 (AGAP010310), eRF3 (AGAP009310), UPF1 (AGAP001133), UPF2 (AGAP000337), UPF3 (AGAP006649), eIF4AIII (AGAP003089), Y14 (AGAP006365)/MAGOH (AGAP010755), SMG1(AGAP000368), SMG5 (AGAP008181), SMG6 (AGAP000894), PP2A (AGAP004096), Musashi (AGAP001930) | UPF1 (PF3D7_1005500), UPF2 (PF3D7_0925800), UPF3B (PF3D7_1327700), eIF4AIII (PF3D7_0422700) PF3D7_1327700), PP2A(PF3D7_0925400 – KEGG, PF3D7_1319700 – Hs homology, or PF3D7_0927700 – name), Musashi (PF3D7_0916700), PABP1 (PF3D7_1224300), eRF1 (PF3D7_0212300), eRF3 (PF3D7_1123400) |
| NGD/NSD | Pelota/HBS1L, RACK1, ZNF598, N4BP2 (Cue2) | Pelota (AGAP008269), HBS1L (AGAP002603), RACK1 (AGAP010173), ZNF598 homolog (AGAP007725), N4BP2 homolog (AGAP002516) | Pelota (PF3D7_0722100), RACK1 (PF3D7_0826700), ZNF598 (PF3D7_1450400) |
| RQC | CNOT4, ABCE1, TRIP4, ASCC2, ASCC3, NEMF, Listerin, UBE2D1, XRN1 | CNOT4, ABCE1 (AGAP002182), ASCC2 homolog (AGAP000428), ASCC3 (AGAP001234), NEMF homolog (AGAP002680), Ltn1 (AGAP007143), UBE2D1 homolog (AGAP000145), XRN1 | ABCE1 (PF3D7_1368200), NEMF homolog (PF3D7_1202600), Listerin homolog (PF3D7_0615600), CNOT4 (PF3D7_1235300), ASCC3 homolog (PF3D7_1439100), UBE2D1 homolog (PF3D7_1203900) XRN1 (PF3D7_0909400) |